March 22, 2018 / 9:12 AM / 4 months ago

BRIEF-Shanghai RAAS Blood Products Plans Asset Acquisition, Share Trade Remains Suspended

March 22 (Reuters) - Shanghai RAAS Blood Products Co Ltd :

* SAYS IT PLANS TO BUY TIANCHENG INTERNATIONAL INVESTMENT OR ITS SUBSIDIARY VALUED AT 16 BILLION YUAN ($2.53 billion) VIA SHARE ISSUE

* SAYS TIANCHENG INTERNATIONAL INVESTMENT OWNS BIO PRODUCTS LABORATORY HOLDINGS, BIOTEST AG

* SAYS SHARE TRADE REMAINS SUSPENDED Source text in Chinese: bit.ly/2Gdtyr2 Further company coverage: ($1 = 6.3230 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below